- Business Wire•7 hours ago
CEL-SCI Corporation announces that the NYSE MKT has accepted the Company’s plan to bring itself into compliance with the Exchange's continued listing standards.
- Business Wire•6 days ago
CEL-SCI Corporation today announced that Dr. Daniel Zimmerman, its Senior V.P of Research, Cellular Immunology, presented data with a LEAPS Rheumatoid Arthritis therapeutic vaccine at Madridge‘s International Conference on Vaccines held in Baltimore, MD on February 20-22, 2017.
- Business Wire•10 days ago
CEL-SCI Corporation today announced it has entered into a definitive agreement with institutional investors for an offering of shares of common stock with gross proceeds of approximately $1.0 million in a registered direct offering.
CVM : Summary for Cel-Sci Corporation Common Stoc - Yahoo Finance
CEL-SCI Corporation (CVM)
NYSE MKT - NYSE MKT Real Time Price. Currency in USD
Add to watchlist
|Day's Range||0.09 - 0.10|
|52 Week Range||0.06 - 0.66|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-1.18|
|Dividend & Yield||0.00 (0.00%)|
|1y Target Est||N/A|